Detalles de la búsqueda
1.
Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes.
N Engl J Med
; 390(15): 1394-1407, 2024 04 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38587233
2.
Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity.
N Engl J Med
; 389(12): 1069-1084, 2023 Sep 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37622681
3.
Effect of Dapagliflozin Versus Placebo on Symptoms and 6-Minute Walk Distance in Patients With Heart Failure: The DETERMINE Randomized Clinical Trials.
Circulation
; 149(11): 825-838, 2024 03 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38059368
4.
Effects of Semaglutide on Symptoms, Function, and Quality of Life in Patients With Heart Failure With Preserved Ejection Fraction and Obesity: A Prespecified Analysis of the STEP-HFpEF Trial.
Circulation
; 149(3): 204-216, 2024 01 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37952180
5.
Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials.
Lancet
; 403(10437): 1635-1648, 2024 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38599221
6.
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.
N Engl J Med
; 387(12): 1089-1098, 2022 09 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36027570
7.
Semaglutide and Diuretic Use in Obesity-Related Heart Failure with Preserved Ejection Fraction: A Pooled Analysis of the STEP-HFpEF and STEP-HFpEF-DM trials.
Eur Heart J
; 2024 May 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38739118
8.
Racial Differences in Quality of Life in Patients With Heart Failure Treated With Sodium-Glucose Cotransporter 2 Inhibitors: A Patient-Level Meta-Analysis of the CHIEF-HF, DEFINE-HF, and PRESERVED-HF Trials.
Circulation
; 148(3): 220-228, 2023 07 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37191040
9.
Outpatient Worsening Among Patients With Mildly Reduced and Preserved Ejection Fraction Heart Failure in the DELIVER Trial.
Circulation
; 148(22): 1735-1745, 2023 11 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37632455
10.
Clinical Characteristics and Outcomes in Patients With Heart Failure: Are There Thresholds and Inflection Points in Left Ventricular Ejection Fraction and Thresholds Justifying a Clinical Classification?
Circulation
; 148(9): 732-749, 2023 08 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37366061
11.
Dapagliflozin and Apparent Treatment-Resistant Hypertension in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The DELIVER Trial.
Circulation
; 148(24): 1945-1957, 2023 12 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37830208
12.
Sex Differences in Characteristics, Outcomes, and Treatment Response With Dapagliflozin Across the Range of Ejection Fraction in Patients With Heart Failure: Insights From DAPA-HF and DELIVER.
Circulation
; 147(8): 624-634, 2023 02 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36342789
13.
Myeloperoxidase Inhibition in Heart Failure With Preserved or Mildly Reduced Ejection Fraction: SATELLITE Trial Results.
J Card Fail
; 30(1): 104-110, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37072105
14.
Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction: Rationale, Design and Lead-in Phase Results of the REBALANCE-HF Trial.
J Card Fail
; 2024 Jan 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38211934
15.
Heart Failure, Investigator-Reported Sleep Apnea and Dapagliflozin: A Patient-Level Pooled Meta-Analysis of DAPA-HF and DELIVER.
J Card Fail
; 30(3): 436-448, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38104937
16.
Understanding the Pathobiology of Pulmonary Hypertension Due to Left Heart Disease.
Circ Res
; 130(9): 1382-1403, 2022 04 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-35482841
17.
Development and Validation of a Long-Term Incident Heart Failure Risk Model.
Circ Res
; 130(2): 200-209, 2022 01 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-34886685
18.
Dapagliflozin and diuretic utilization in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial.
Eur Heart J
; 44(31): 2930-2943, 2023 08 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37220093
19.
Heart failure, peripheral artery disease, and dapagliflozin: a patient-level meta-analysis of DAPA-HF and DELIVER.
Eur Heart J
; 44(24): 2170-2183, 2023 06 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37220172
20.
Elucidating the Clinical Implications and Pathophysiology of Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: A Call to Action: A Science Advisory From the American Heart Association.
Circulation
; 146(7): e73-e88, 2022 08 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35862198